Skip to main content
SpringerLink
Log in

Unilateral lymphoedema after a second dose of BNT162b2 COVID-19 mRNA vaccine

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med 2020; 383: 2603–15.

    Article  CAS  PubMed  Google Scholar 

  2. Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting. N Engl J Med 2021; 385: 1078–90.

    Article  CAS  PubMed  Google Scholar 

  3. Chung JH, Sohn SM, Yoo HJ, Yoon ES, Park SH. Transient lower extremity lymphedema following COVID-19 vaccination: a case report. Med (Baltimore) 2021; 100: e28092.

    Article  CAS  Google Scholar 

  4. Tang CYL, Chua WM. Ipsilateral upper-limb lymphedema after COVID-19 vaccine booster. Clin Mucl Med 2023; 48: 264–5.

    Google Scholar 

  5. Hosseinzadeh A, Ebrahimi K, Shahriarirad R, Dalfardi F. Lower limb lymphedema and cellulitis as a complication of COVID-19 vaccine: a case report. Clin Case Rep 2022; 10: e6317.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol 2017; 77: 1009–20.

    Article  PubMed  Google Scholar 

  7. Padera TP, Meijer EF, Munn LL. The lymphatic system in disease processes and cancer progression. Annu Rev Biomed Eng 2016; 18: 125–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Miyasaka M. The lymphatic system and COVID-19 vaccines. Front Immunol 2022; 13: 1041025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine. Eur J Nucl Med Mol Imaging 2021; 48: 1854–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahabacho, Iwate, 028-3695, Japan

    Daisuke Watabe & Hiroo Amano

Authors
  1. Daisuke Watabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroo Amano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daisuke Watabe.

Ethics declarations

Conflicts of interest: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watabe, D., Amano, H. Unilateral lymphoedema after a second dose of BNT162b2 COVID-19 mRNA vaccine. Eur J Dermatol 33, 312–314 (2023). https://doi.org/10.1684/ejd.2023.4491

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2023.4491

Search

Navigation